{"id":555083,"date":"2026-04-28T21:33:58","date_gmt":"2026-04-28T19:33:58","guid":{"rendered":"https:\/\/medizinonline.com\/?p=555083"},"modified":"2026-04-28T21:34:08","modified_gmt":"2026-04-28T19:34:08","slug":"les-options-therapeutiques-ciblees-gagnent-du-terrain","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/les-options-therapeutiques-ciblees-gagnent-du-terrain\/","title":{"rendered":"Les options th\u00e9rapeutiques cibl\u00e9es gagnent du terrain"},"content":{"rendered":"\n<p><strong>La pathophysiologie du prurigo nodulaire (PN) est multifactorielle et complexe, mais des progr\u00e8s importants ont \u00e9t\u00e9 r\u00e9alis\u00e9s r\u00e9cemment en ce qui concerne les options th\u00e9rapeutiques. Outre les anticorps monoclonaux dupilumab et nemolizumab, approuv\u00e9s sur la base des \u00e9tudes PRIME\/PRIME2 et du programme d&#8217;\u00e9tudes OLYMPIA, plusieurs agents syst\u00e9miques sont actuellement en cours d&#8217;\u00e9valuation dans le cadre d&#8217;essais cliniques de phase II et III, dont plusieurs anticorps monoclonaux et inhibiteurs de Janus kinase. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fles-options-therapeutiques-ciblees-gagnent-du-terrain%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>La pathophysiologie du prurigo nodulaire (PN) est multifactorielle et complexe, mais des progr\u00e8s importants ont \u00e9t\u00e9 r\u00e9alis\u00e9s r\u00e9cemment en ce qui concerne les options th\u00e9rapeutiques. Outre les anticorps monoclonaux dupilumab&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fles-options-therapeutiques-ciblees-gagnent-du-terrain%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":555084,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Prurigo nodulaire : traitement fond\u00e9 sur des donn\u00e9es probantes  ","footnotes":""},"category":[11349,11362,11527,11531,11464,11549],"tags":[67540,82320,12635,9048,91506,91487,65362,85865,83398,91484,65751,83396],"powerkit_post_featured":[],"class_list":["post-555083","post","type-post","status-publish","format-standard","has-post-thumbnail","category-allergologie-et-immunologie-clinique","category-dermatologie-et-venerologie","category-etudes","category-formation-continue","category-pharmacologie-et-toxicologie","category-rx-fr","tag-abrocitinib","tag-barzolvolimab","tag-demangeaisons","tag-dupilumab","tag-modulateurs-dopiaces","tag-nalbuphin","tag-nemolizumab","tag-olympia","tag-povorcitinib","tag-prime-prime2","tag-prurigo-nodulaire","tag-vixarelimab","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-06 01:44:58","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":555097,"slug":"le-opzioni-di-terapia-mirata-sono-in-aumento","post_title":"Le opzioni di terapia mirata sono in aumento","href":"https:\/\/medizinonline.com\/it\/le-opzioni-di-terapia-mirata-sono-in-aumento\/"},"pt_PT":{"locale":"pt_PT","id":555087,"slug":"as-opcoes-de-terapia-direcionada-estao-a-aumentar","post_title":"As op\u00e7\u00f5es de terapia direcionada est\u00e3o a aumentar","href":"https:\/\/medizinonline.com\/pt-pt\/as-opcoes-de-terapia-direcionada-estao-a-aumentar\/"},"es_ES":{"locale":"es_ES","id":555096,"slug":"aumentan-las-opciones-de-terapia-dirigida","post_title":"Aumentan las opciones de terapia dirigida","href":"https:\/\/medizinonline.com\/es\/aumentan-las-opciones-de-terapia-dirigida\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/555083","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=555083"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/555083\/revisions"}],"predecessor-version":[{"id":555085,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/555083\/revisions\/555085"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/555084"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=555083"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=555083"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=555083"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=555083"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}